Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
15090 | 663 | 42.8 | 66% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | NEONATAL 6 HYDROXYDOPAMINE | Author keyword | 6 | 80% | 1% | 4 |
2 | SUPERSENSITIZATION | Author keyword | 5 | 43% | 1% | 9 |
3 | PPE MESSENGER RNA | Author keyword | 4 | 75% | 0% | 3 |
4 | CELLULAR CLIN NEUROBIOL PROGRAM | Address | 4 | 21% | 2% | 15 |
5 | SEROTONIN HYPERINNERVATION | Author keyword | 3 | 100% | 0% | 3 |
6 | ORAL ACTIVITY | Author keyword | 3 | 30% | 1% | 9 |
7 | RECEPTOR SUPERSENSITIVITY | Author keyword | 3 | 31% | 1% | 8 |
8 | PREPROTACHYKININ | Author keyword | 3 | 19% | 2% | 13 |
9 | PREPROENKEPHALIN MESSENGER RNA | Author keyword | 2 | 32% | 1% | 6 |
10 | PREPROENKEPHALIN MRNA | Author keyword | 2 | 32% | 1% | 6 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DEPLETING BRAIN LESIONS | 37 | 52% | 8% | 50 |
2 | ORAL ACTIVITY RESPONSES | 29 | 88% | 2% | 14 |
3 | NEONATAL 6 OHDA LESIONED RATS | 14 | 51% | 3% | 19 |
4 | 6 HYDROXYDOPAMINE TREATMENTS | 8 | 75% | 1% | 6 |
5 | ONTOGENIC HOMOLOGOUS SUPERSENSITIZATION | 8 | 100% | 1% | 5 |
6 | SEROTONIN HYPERINNERVATED NEOSTRIATUM | 8 | 100% | 1% | 5 |
7 | NIGROSTRIATAL BUNDLE DAMAGE | 7 | 50% | 2% | 10 |
8 | NIGRAL SUBSTANCE P | 6 | 80% | 1% | 4 |
9 | INTRAVENTRICULAR 6 HYDROXYDOPAMINE | 6 | 53% | 1% | 8 |
10 | ATYPICAL NEUROLEPTIC TREATMENT | 4 | 67% | 1% | 4 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Serotonin neural adaptations to ontogenetic loss of dopamine neurons in rat brain | 1998 | 51 | 77 | 66% |
DOPAMINE-RECEPTOR SUPERSENSITIVITY | 1995 | 91 | 94 | 61% |
Effects of denervation and hyperinnervation on dopamine and serotonin systems in the rat neostriatum: implications for human Parkinson's disease | 1999 | 43 | 178 | 43% |
Do compensatory processes underlie the preclinical phase of neurodegenerative disease? Insights from an animal model of parkinsonism | 1997 | 65 | 32 | 47% |
The neonate-6-hydroxydopamine-lesioned rat: a model for clinical neuroscience and neurobiological principles | 2005 | 39 | 138 | 44% |
PREPROENKEPHALIN AND PREPROTACHYKININ MESSENGER-RNA EXPRESSION IN NORMAL HUMAN BASAL GANGLIA AND IN PARKINSONS-DISEASE | 1995 | 76 | 86 | 35% |
DOPAMINERGIC REGULATION OF GLUTAMIC-ACID DECARBOXYLASE MESSENGER-RNA EXPRESSION AND GABA RELEASE IN THE STRIATUM - A REVIEW | 1993 | 62 | 15 | 40% |
MOLECULAR ASPECTS OF NEUROPEPTIDE REGULATION AND FUNCTION IN THE CORPUS STRIATUM AND NUCLEUS-ACCUMBENS | 1994 | 176 | 194 | 14% |
Differential effects of bilateral dopamine depletion in neonatal and adult rats | 1997 | 18 | 104 | 47% |
Increased number of [I-125] BH-substance P receptors in schizophrenia | 1998 | 6 | 13 | 54% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CELLULAR CLIN NEUROBIOL PROGRAM | 4 | 21% | 2.3% | 15 |
2 | DENT PROPEDEUT | 1 | 33% | 0.5% | 3 |
3 | BEIJING NEURAL REGENERAT REPAIRMINIST EDUC | 1 | 50% | 0.2% | 1 |
4 | CAROLINA NEUROSCI | 1 | 50% | 0.2% | 1 |
5 | COMPUTAT STRUCT SCI MASS SPE OMETRY | 1 | 50% | 0.2% | 1 |
6 | EXPT PARKINSONISM | 1 | 50% | 0.2% | 1 |
7 | GENET BASES NEUROENDOCRINE REGULAT | 1 | 50% | 0.2% | 1 |
8 | QUILLEN DISHNER MED | 0 | 11% | 0.6% | 4 |
9 | IFIBIO HOUSSAY | 0 | 33% | 0.2% | 1 |
10 | STRUCT MOL NEUROSCI | 0 | 33% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000136411 | TONICALLY ACTIVE NEURONS//NEOSTRIATUM//THALAMOSTRIATAL PROJECTIONS |
2 | 0.0000130047 | SCH 39166//DIHYDREXIDINE//DOPAMINE D1 RECEPTORS |
3 | 0.0000120628 | PROENKEPHALIN//PROENKEPHALINS//PRO ENKEPHALIN |
4 | 0.0000116064 | AS AGU RAT//THIGMOTACTIC SCANNING//TELENCEPHALON ABLATION |
5 | 0.0000114946 | VACUOUS CHEWING MOVEMENTS//TARDIVE DYSKINESIA//OROFACIAL DYSKINESIA |
6 | 0.0000112139 | LESCH NYHAN SYNDROME//LESCH NYHAN DISEASE//LESCH NYHAN |
7 | 0.0000111648 | CGP 43487//L TRANS PYRROLIDINE 3 4 DICARBOXYLIC ACID//NEUROCYTOL RD29 |
8 | 0.0000103192 | AMINE ACCUMULATION//CATIONIZED POLYACRYLAMIDE//LONG TERM DEFICITS |
9 | 0.0000101323 | GABA SYNTHESIS//GLUTAMATE DECARBOXYLASE//GAMMA VINYL GAMMA AMINOBUTYRIC ACID |
10 | 0.0000077117 | PERINATAL ASPHYXIA//NEONATAL ANOXIA//PROGRAMME MOL CLIN PHARMACOL |